{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:06:20Z","timestamp":1790845580480,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T00:00:00Z","timestamp":1513382400000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Elevated levels of low-density lipoprotein cholesterol (LDL-C) and glycosylated hemoglobin (HbA1c) are risk factors for cardiovascular complications. This study evaluated LDL-C goal attainment in Russian clinical practice among patients with moderate to very high cardiovascular risk. The study also assessed LDL-C goal attainment in patients prescribed lipid-lowering therapy for primary compared with secondary cardiovascular disease (CVD) prevention, predictors of LDL-C goal attainment, and the proportion of individuals with diabetes mellitus who achieved HbA1c\u00a0&lt;\u00a07%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia in Russia II (CEPHEUS II) was a multicenter, non-interventional, cross-sectional study conducted in the Russian Federation from September 2014 to November 2015. Participants were aged\u00a0\u2265\u00a018\u00a0years, were receiving a stable dose of lipid-lowering medication and had a moderate to very high cardiovascular risk. The primary variable was the proportion of patients reaching LDL-C goals established by the Fifth Joint European Task Force guidelines. Secondary analyses used McNemar and \u03c7<jats:sup>2<\/jats:sup> tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data from 2703 patients were analyzed; 91.2% had a very high cardiovascular risk and 24.0% had been diagnosed with diabetes mellitus. Overall, 17.4% of patients (95% confidence interval [CI] 15.9\u201318.8%) achieved LDL-C goals. Investigators estimated this proportion at 21.8% (95% CI 20.3\u201323.4%). LDL-C goals were achieved by more patients in the primary CVD prevention subgroup than in the secondary CVD prevention subgroup (19.7% vs 16.1%, p\u00a0=\u00a00.017). Patient-related factors associated with a decreased likelihood of achieving LDL-C goals included having ischemic heart disease or a family history of premature coronary heart disease, forgetting to take hypercholesterolemia treatment or considering it acceptable to miss prescribed doses more than once per week, and dissatisfaction with or concern about lipid-lowering therapy. Overall, 367\/593 (61.9%) patients with diabetes mellitus and interpretable HbA1c results achieved HbA1c\u00a0&lt;\u00a07%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Hypercholesterolemia management is suboptimal in patients with moderate to very high cardiovascular risk in Russian clinical practice. Substantial opportunity remains to improve treatment target attainment and reduce the risk of cardiovascular complications. Lipid-modifying strategies may need to be intensified to reduce CVD risk in this setting.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> ClinicalTrials.gov: NCT02230241 (registered 26 August 2014)<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-017-0641-4","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T19:26:01Z","timestamp":1513365961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)"],"prefix":"10.1186","volume":"16","author":[{"given":"Sergey","family":"Boytsov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Logunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunona","family":"Khomitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the CEPHEUS II investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eradzh","family":"Nuraliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya","family":"Lebedeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inessa","family":"Shchelkunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vershuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Zhidkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Rostorotskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Shadaniya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Zobenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kvasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Zikun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Glushchenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rumyantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Prokof\u2019eva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Baturova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodion","family":"Oseshnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zhukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shumikhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Eltisheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Bugaets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Chernysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ivochkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Svistunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Klimenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kulchitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Alexandrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Chernysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Ivanchura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Chachshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Afonina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Chernyshev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniya","family":"Korostyleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Staroverova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy","family":"Badin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Il\u2019icheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Monetkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Novikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Abashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Plaksina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Kostomarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Alieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Budanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inessa","family":"Kartashova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Chepurnenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Oreshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Skachkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rkiya","family":"Khanbekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pashchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Zolotova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Volodina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya","family":"Shurkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vikhman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Poshinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniil","family":"Cherepnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Leonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kargina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Gerent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Nabokikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Sokolovskikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Tkhorikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Titova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Rachkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Baglikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinsa","family":"Giorgadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Malygin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Strelkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Ryzhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kochladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Vyasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Vasiliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Bondarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mokhnacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Shumilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Pakhomova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,16]]},"reference":[{"key":"641_CR1","unstructured":"World Health Organization (WHO). Cardiovascular diseases (CVDs) fact sheet. http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en. Accessed 22 Jul 2017."},{"key":"641_CR2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","volume":"370","author":"Prospective Studies Collaboration","year":"2007","unstructured":"Collaboration Prospective Studies, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829\u201339.","journal-title":"Lancet"},{"key":"641_CR3","first-page":"305","volume":"48","author":"MR Law","year":"1994","unstructured":"Law MR, Wald NJ. An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur J Clin Nutr. 1994;48:305\u201325.","journal-title":"Eur J Clin Nutr"},{"key":"641_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12916-016-0570-1","volume":"14","author":"B Sch\u00f6ttker","year":"2016","unstructured":"Sch\u00f6ttker B, Rathmann W, Herder C, Thorand B, Wilsgaard T, Nj\u00f8lstad I, et al. HbA1c levels in non-diabetic older adults\u2014no J-shaped associations with primary cardiovascular events, cardiovascular and all-cause mortality after adjustment for confounders\u00a0in a meta-analysis of individual participant data from six cohort studies. BMC Med. 2016;14:26.","journal-title":"BMC Med"},{"key":"641_CR5","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group","year":"2005","unstructured":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643\u201353.","journal-title":"N Engl J Med"},{"key":"641_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405\u201312.","journal-title":"BMJ"},{"key":"641_CR7","first-page":"CD004816","volume":"1","author":"F Taylor","year":"2013","unstructured":"Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816.","journal-title":"Cochrane Database Syst Rev"},{"key":"641_CR8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/archinternmed.2012.2145","volume":"172","author":"J Gutierrez","year":"2012","unstructured":"Gutierrez J, Ramirez G, Rundek T, Sacco RL. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med. 2012;172:909\u201319.","journal-title":"Arch Intern Med"},{"issue":"14","key":"641_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12933-015-0268-2","volume":"25","author":"Y Karpov","year":"2015","unstructured":"Karpov Y, Khomitskaya Y. PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia. Cardiovasc Diabetol. 2015;25(14):115.","journal-title":"Cardiovasc Diabetol"},{"key":"641_CR10","doi-asserted-by":"crossref","unstructured":"Boytsov SA, Khomitskaya Y; on behalf of the CEPHEUS study group. Centralised Survey on the Undertreatment of the Hypercholesterolemia in Russia (CEPHEUS). \u041aap\u0434\u0438o\u0432ac\u043ay\u043b\u044fp\u043da\u044f \u0442epa\u043f\u0438\u044f \u0438 \u043fpo\u0444\u0438\u043ba\u043a\u0442\u0438\u043aa [Cardiovasc Ther Prev]. 2013;12:4\u201311.","DOI":"10.15829\/1728-8800-2013-4-67-74"},{"key":"641_CR11","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","volume":"28","author":"I Graham","year":"2007","unstructured":"Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375\u2013414.","journal-title":"Eur Heart J"},{"key":"641_CR12","unstructured":"\u041ayxap\u0447y\u043a [Kukharchuk] BB. \u0414\u0438a\u0433\u043doc\u0442\u0438\u043aa \u0438 \u043aoppe\u043a\u0446\u0438\u044f \u043dapy\u0448e\u043d\u0438\u0439 \u043b\u0438\u043f\u0438\u0434\u043do\u0433o o\u0431\u043ce\u043da c \u0446e\u043b\u044c\u044e \u043fpo\u0444\u0438\u043ba\u043a\u0442\u0438\u043a\u0438 \u0438 \u043be\u0447e\u043d\u0438\u044f a\u0442epoc\u043a\u043bepo\u0437a [Diagnosis and correction of lipid metabolism, with a view to the prevention and treatment of atherosclerosis]. Moc\u043a\u0432a [Moscow]; 2007. p. 18."},{"issue":"33","key":"641_CR13","first-page":"1635","volume":"2012","author":"J Perk","year":"2012","unstructured":"Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012).The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;2012(33):1635\u2013701.","journal-title":"Eur Heart J"},{"key":"641_CR14","unstructured":"\u041ayxap\u0447y\u043a [Kukharchuk] BB, Cyce\u043ao\u0432 [Susekov] AB, \u0417y\u0431ape\u0432a M\u042e [Zubareva MJ], \u0413op\u043d\u044f\u043ao\u0432a H.\u0411 [Gornyakova NB]. \u0414\u0438a\u0433\u043doc\u0442\u0438\u043aa \u0438 \u043aoppe\u043a\u0446\u0438\u044f \u043dapy\u0448e\u043d\u0438\u0439 \u043b\u0438\u043f\u0438\u0434\u043do\u0433o o\u0431\u043ce\u043da c \u0446e\u043b\u044c\u044e \u043fpo\u0444\u0438\u043ba\u043a\u0442\u0438\u043a\u0438 \u0438 \u043be\u0447e\u043d\u0438\u044f a\u0442epoc\u043a\u043bepo\u0437a [Diagnosis and correction of lipid metabolism, with a view to the prevention and treatment of atherosclerosis]. \u041aap\u0434\u0438o\u0432ac\u043ay\u043b\u044fp\u043da\u044f \u0442epa\u043f\u0438\u044f \u0438 \u043fpo\u0444\u0438\u043ba\u043a\u0442\u0438\u043aa [Cardiovascular Therapy and Prevention]. 2009;8(6 [Suppl 3])."},{"key":"641_CR15","first-page":"5","volume":"4","author":"Russian Society of Cardiology","year":"2012","unstructured":"Russian Society of Cardiology. Diagnosis and correction of lipid metabolism, with a view to the prevention and treatment of atherosclerosis Russian recommendations. Review V. Atheroscler Dyslipidaemia. 2012;4:5\u201352 (In Russian).","journal-title":"Atheroscler Dyslipidaemia"},{"key":"641_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5551\/jat.31179","volume":"23","author":"CE Chiang","year":"2016","unstructured":"Chiang CE, Ferri\u00e8res J, Gotcheva NN, Raal FJ, Shehab A, Sung J, et al. Suboptimal control of lipid levels: results from 29 countries participating in the Centralized Pan-Regional Surveys on the Undertreatment of Hypercholesterolaemia (CEPHEUS). J Atheroscler Thromb. 2016;23:567\u201387.","journal-title":"J Atheroscler Thromb"},{"key":"641_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"641_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1\u201345.","journal-title":"Circulation"},{"key":"641_CR19","doi-asserted-by":"publisher","first-page":"e0115270","DOI":"10.1371\/journal.pone.0115270","volume":"10","author":"JP Halcox","year":"2015","unstructured":"Halcox JP, Tubach F, Lopez-Garcia E, De Backer G, Borghi C, Dallongeville J, et al. Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe. PLoS ONE. 2015;10:e0115270.","journal-title":"PLoS ONE"},{"key":"641_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2016.01.018","volume":"246","author":"\u017d Reiner","year":"2016","unstructured":"Reiner \u017d, De Backer G, Fras Z, Kotseva K, Tokg\u00f6zoglu L, Wood D, et al. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries\u2014findings from the EUROASPIRE IV survey. Atherosclerosis. 2016;246:243\u201350.","journal-title":"Atherosclerosis."},{"key":"641_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.18565\/cardio.2015.12.99-107","volume":"55","author":"NV Pogosova","year":"2015","unstructured":"Pogosova NV, Oganov RG, Boytsov SA, Ausheva AK, Sokolova OJ, Kursakov AA, et al. Monitoring the secondary prevention of coronary artery disease in Europe and Russia: results of the Russian part of the international multicenter study EUROASPIRE IV. Kardiologiia. 2015;55:99\u2013107.","journal-title":"Kardiologiia"},{"key":"641_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1185\/03007990903500565","volume":"26","author":"MP Hermans","year":"2010","unstructured":"Hermans MP, Castro Cabezas M, Strandberg T, Ferri\u00e8res J, Feely J, Elisaf M, et al. Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries. Curr Med Res Opin. 2010;26:445\u201354.","journal-title":"Curr Med Res Opin"},{"key":"641_CR23","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2337\/dc12-2258","volume":"36","author":"S Stark Casagrande","year":"2013","unstructured":"Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988\u20132010. Diabetes Care. 2013;36:2271\u20139.","journal-title":"Diabetes Care"},{"key":"641_CR24","unstructured":"International Diabetes Federation (IDF). IDF diabetes atlas, 7th edn. http:\/\/www.diabetesatlas.org. Accessed 22 Jul 2017."},{"key":"641_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12933-016-0412-7","volume":"15","author":"PD Rosenblit","year":"2016","unstructured":"Rosenblit PD. Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile? Cardiovasc Diabetol. 2016;15:95.","journal-title":"Cardiovasc Diabetol."},{"key":"641_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1475-2840-8-26","volume":"8","author":"PP Toth","year":"2009","unstructured":"Toth PP, Zarotsky V, Sullivan JM, Laitinen D. Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis. Cardiovasc Diabetol. 2009;8:26.","journal-title":"Cardiovasc Diabetol."},{"key":"641_CR27","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/jama.2017.3416","volume":"317","author":"NJ Pagidipati","year":"2017","unstructured":"Pagidipati NJ, Navar AM, Mulder H, Sniderman AD, Peterson ED, Pencina MJ. Comparison of recommended eligibility for primary prevention statin therapy based on the US Preventive Services Task Force recommendations vs the ACC\/AHA guidelines. JAMA. 2017;317:1563\u20137.","journal-title":"JAMA"},{"key":"641_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12933-016-0400-y","volume":"15","author":"MB Mortensen","year":"2016","unstructured":"Mortensen MB, Kulenovic I, Falk E. Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction. Cardiovasc Diabetol. 2016;15:81.","journal-title":"Cardiovasc Diabetol"},{"key":"641_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12933-016-0391-8","volume":"15","author":"B Bohn","year":"2016","unstructured":"Bohn B, Sch\u00f6fl C, Zimmer V, Hummel M, Heise N, Siegel E, et al. Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German\/Austrian DPV-multicenter analysis. Cardiovasc Diabetol. 2016;15:72.","journal-title":"Cardiovasc Diabetol"},{"key":"641_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12933-016-0341-5","volume":"15","author":"L Masmiquel","year":"2016","unstructured":"Masmiquel L, Leiter LA, Vidal J, Bain S, Petrie J, Franek E, et al. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial. Cardiovasc Diabetol. 2016;15:29.","journal-title":"Cardiovasc Diabetol"},{"key":"641_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12933-017-0548-0","volume":"16","author":"M Hanefeld","year":"2017","unstructured":"Hanefeld M, Traylor L, Gao L, Landgraf W. The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100\u00a0U\/mL. Cardiovasc Diabetol. 2017;16:66.","journal-title":"Cardiovasc Diabetol"},{"key":"641_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jacl.2016.06.011","volume":"10","author":"ND Wong","year":"2016","unstructured":"Wong ND, Young D, Zhao Y, Nguyen H, Caballes J, Khan I, et al. Prevalence of the American College of Cardiology\/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011\u20132012. J Clin Lipidol. 2016;10:1109\u201318.","journal-title":"J Clin Lipidol"},{"key":"641_CR33","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cjca.2016.12.019","volume":"33","author":"D Gaudet","year":"2017","unstructured":"Gaudet D, Drouin-Chartier JP, Couture P. Lipid metabolism and emerging targets for lipid-lowering therapy. Can J Cardiol. 2017;33:872\u201382.","journal-title":"Can J Cardiol"},{"issue":"Suppl 1","key":"641_CR34","first-page":"S6","volume":"24","author":"YU Khomitskaya","year":"2017","unstructured":"Khomitskaya YU, Logunova NA, Boytsov SA. Positive and negative predictors of LDL-C goals achievement in patients at moderate to very high cardiovascular risk on lipid-lowering drug therapy (CEPHEUS II). Eur J Prev Cardiol. 2017;24(Suppl 1):S6.","journal-title":"Eur J Prev Cardiol"},{"key":"641_CR35","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1016\/j.atherosclerosis.2017.06.770","volume":"263","author":"NA Logunova","year":"2017","unstructured":"Logunova NA, Gurina N, Boytsov SA. Achievement of LDL-C goals in patients at moderate to very high cardiovascular risk on lipid-lowering drug therapy (CEPHEUS II). Atherosclerosis. 2017;263:e236\u20137.","journal-title":"Atherosclerosis"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0641-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-017-0641-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0641-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:05:15Z","timestamp":1628597115000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-017-0641-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1186\/s12933-017-0641-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"8 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"158"}}